Lifeness: Difference between revisions
Created from NHT member research |
Created with researched data |
||
| Line 1: | Line 1: | ||
{{ | {{DISPLAYTITLE:Lifeness}} | ||
|name=Lifeness | {{Infobox company | ||
| | | name = Lifeness AS | ||
| | | org_number = 921141130 | ||
| | | founded = 2018-06-28 | ||
| | | employees = 8 | ||
| | | address = Norway | ||
| industry = 62.100 – Computer programming | |||
| website = https://lifeness.io | |||
| nht_category = Startup | |||
| description = Lifeness provides personalized digital health therapy programs for weight loss and metabolic health. The program combines personal follow-up with digital tools, offering a holistic medical treatment program for weight loss. Has a partnership with Novo Nordisk France to optimize care pathways for obesity patients. | |||
| notes = 8 employees. Partnership with Novo Nordisk France indicates commercial validation. Digital obesity therapeutics is a large and growing market. | |||
| related_companies = [[Pre Diagnostics]], [[Age Labs]], [[Norway Health Tech]] | |||
| categories = Norway Health Tech, Startups, Digital Therapeutics, Preventive Health, Metabolic Health | |||
| sources = https://lifeness.io; https://data.brreg.no/enhetsregisteret/api/enheter/921141130 | |||
}} | }} | ||
== | == About == | ||
Lifeness AS is a Norwegian digital health company providing personalized health therapy programs focused on weight management and metabolic health. Founded in 2018 with 8 employees. | |||
== | == Products == | ||
== | === Lifeness Program === | ||
[[Category: | A holistic medical treatment program for weight loss combining: | ||
[[Category: | * Personalized digital health interventions | ||
* Individual follow-up and coaching | |||
* Medical supervision | |||
* Digital tools for tracking and engagement | |||
== Notable Partnership == | |||
Lifeness has a partnership with Novo Nordisk France to optimize the care pathway for patients with obesity. Novo Nordisk's GLP-1 receptor agonists (Wegovy, Saxenda) are major treatments for obesity, and Lifeness provides the digital follow-up and support infrastructure. | |||
== Market == | |||
Digital obesity therapeutics is a high-growth market driven by: | |||
* Rising global obesity rates | |||
* Clinical evidence for lifestyle intervention as part of obesity treatment | |||
* Reimbursement evolution for digital health interventions | |||
* Integration with pharmacotherapy (GLP-1 drugs) | |||
== References == | |||
<references/> | |||
[[Category:Norway Health Tech]] | |||
[[Category:Startups]] | |||
[[Category:Digital Therapeutics]] | |||
[[Category:Preventive Health]] | |||
[[Category:Metabolic Health]] | |||
Latest revision as of 20:14, 14 April 2026
About[edit]
Lifeness AS is a Norwegian digital health company providing personalized health therapy programs focused on weight management and metabolic health. Founded in 2018 with 8 employees.
Products[edit]
Lifeness Program[edit]
A holistic medical treatment program for weight loss combining:
- Personalized digital health interventions
- Individual follow-up and coaching
- Medical supervision
- Digital tools for tracking and engagement
Notable Partnership[edit]
Lifeness has a partnership with Novo Nordisk France to optimize the care pathway for patients with obesity. Novo Nordisk's GLP-1 receptor agonists (Wegovy, Saxenda) are major treatments for obesity, and Lifeness provides the digital follow-up and support infrastructure.
Market[edit]
Digital obesity therapeutics is a high-growth market driven by:
- Rising global obesity rates
- Clinical evidence for lifestyle intervention as part of obesity treatment
- Reimbursement evolution for digital health interventions
- Integration with pharmacotherapy (GLP-1 drugs)